Both in Pharmaceuticals
Niagen Bioscience vs Evommune
Over the past year NAGE returned −61.5% and EVMN returned −68.8%; their daily moves had a correlation of 0.21.
NAGE −61.5% EVMN −68.8%Growth of $1, one year, split-adjusted
| Metric | NAGE | EVMN |
|---|---|---|
| Price | $2.52 | $6.36 |
| Market cap | $199.4M | $230.8M |
| Today | +0.80% | +23.25% |
| 1 month | −14.6% | −23.8% |
| 6 months | −47.1% | −73.3% |
| Year to date | −60.4% | −62.9% |
| 1 year | −66.8% | — |
| Revenue growth (YoY) | −4.3% | — |
| Gross margin | 64.8% | — |
| Net margin | 3.2% | — |
| P/E (TTM) | 12.5× | — |
| Price / sales | 1.5× | — |
| Net cash | $66.7M | $200.4M |
| Dividend yield | — | — |
| Volatility (60d) | 47.1% | 85.0% |
| Short % of float | 8.0% | 16.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).